(2R,6S)-4-(tert-Butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid

Catalog No. :
ACWELI940
CAS No. :
1581750-77-7
Molecular Formula :
C11H19NO6
Molecular Weight :
261.27

IUPAC Name:(2R,6S)-4-(tert-butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid

(2R,6S)-4-(tert-Butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$451.00Login to see priceIn stockInquiry
250mg95%$751.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,6S)-4-(tert-Butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid
IUPAC Name(2R,6S)-4-(tert-butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid
Molecular FormulaC11H19NO6
Molecular Weight261.27
SMILESO=C([C@H]1CN(C(OC(C)(C)C)=O)C[C@@H](CO)O1)O
InChI KeyOYVCKUZJORUIFX-JGVFFNPUSA-N
Synonym(2R,6S)-4-(tert-butoxycarbonyl)-6-(hydroxyMethyl)Morpholine-2-carboxylic acid;2,4-Morpholinedicarboxylic acid, 6-(hydroxymethyl)-, 4-(1,1-dimethylethyl) ester, (2R,6S)-;(2R,6S)-4-Boc-6-(hydroxymethyl)morpholine-2-carboxylic acid
CAS No.1581750-77-7

Synthetic Route by SureRoute

1. ACWELI940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZUWV396 route compound structure diagram
    ACZUWV3961093085-91-6 In Stock
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWELI940 route product structure diagram
    ACWELI9401581750-77-7 In Stock
Inquiry

2. ACWELI940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWELI940 route product structure diagram
    ACWELI9401581750-77-7 In Stock
Inquiry

Comments (0)